Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Non-Current Assets came in at $3.5 million in Q4 2025, up 326.76% YoY from $822000.0 in Q4 2024, and up 9.73% on a QoQ basis from $3.2 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 7 years of Non-Current Assets data on file, last reported at $3.5 million in Q4 2025.
- Quarterly Non-Current Assets rose 326.76% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 326.76% YoY) and the FY2025 annual result came in at $3.5 million, up 326.76% from the prior year.
- Non-Current Assets grew to $3.5 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $4.1 million in Q2 2025 to a low of $6000.0 in Q4 2023.
- A 5-year average of $998421.1 and a median of $211000.0 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets sank 97.16% — and 2024, when it soared 13600.0%.
- Tracing FENC's Non-Current Assets over 5 years: stood at $27000.0 in 2021, then surged by 681.48% to $211000.0 in 2022, then slumped by 97.16% to $6000.0 in 2023, then soared by 13600.0% to $822000.0 in 2024, then surged by 326.76% to $3.5 million in 2025.
- The last three Non-Current Assets figures came in at $3.5 million (Q4 2025), $3.2 million (Q3 2025), and $4.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 41,000.00 |